Neoadjuvant Cisplatin and VP-16 Plus Concurrent Chest and Optional Brain Irradiation for Patients with Stage lll Non-Small Cell Lung Carcinoma
Research committees
Publication Information Expand/Collapse
2005
Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group.
Southwest Oncology Group: Two decades of experience in non-small cell lung cancer
PMid: PMID16015548
Therapeutic strategies for combined-modality therapy of locally advanced non-small cell lung cancer: rationale for consolidation docetaxel therapy
2003
Time from treatment to subsequent diagnosis of brain metastases in Stage III non-small cell lung cancer (NSCLC): a retrospective review by the Southwest Oncology Group (SWOG)
2000
Evolution of combined modality therapy for stage III non-small-cell lung cancer
1999
Long-term survival after concurrent cisplatin/etoposide (PE) plus chest radiotherapy (RT) followed by surgery in bulky, stages IIIA(N2) and IIIB non-small cell lung cancer (NSCLC): 6-year outcomes from Southwest Oncology Group Study 8805.
Summary of the proceedings of the United States - Japan lung cancer clinical trials summit: San Francisco, California, 20-22 November, 1998.
Preoperative chemotherapy in stage III non-small cell lung cancer: long -term outcome
1997
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805.
1995
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805
1994
Concurrent cisplatin/etoposide (PE) plus chest radiation followed by surgery for stages 3A(N2) and 3B non-small cell lung cancer: Completed analysis of SWOG-8805.
Neoadjuvant therapy: A novel and effective treatment for stage IIIb non-small cell lung cancer
1993
Surgical resection of stage IIIA and stage IIIB non-small cell lung cancer after concurrent induction chemoradiotherapy.
1991
Concurrent cisplatin (DDP), VP-16, and chest irradiation (RT) followed by surgery for stages IIIa and IIIb non-small cell lung cancer (NSCLC): A Southwest Oncology Group study.